wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38987587-73149C71-9A33-462C-8910-BA8BEA8545FB
Q38987587-73149C71-9A33-462C-8910-BA8BEA8545FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38987587-73149C71-9A33-462C-8910-BA8BEA8545FB
Cytochrome 2B6 polymorphism and efavirenz-induced central nervous system symptoms : a substudy of the ANRS ALIZE trial.
P2860
Q38987587-73149C71-9A33-462C-8910-BA8BEA8545FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38987587-73149C71-9A33-462C-8910-BA8BEA8545FB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c0c6cb7e001fa59f07f69b04630e9aef54382de7
P2860
Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study.